Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes

2011 ◽  
Vol 22 (6) ◽  
pp. 572-575 ◽  
Author(s):  
Dimitrios Vassilopoulos
Sign in / Sign up

Export Citation Format

Share Document